Finland's Modulight Q4 revenue rises, helped by growth in PPT business

Modulight Oyj

20/02/2026 09:17

Overview

Finland life science firm's Q4 revenue rose 21% yr/yr

Q4 EBITDA improved to EUR 641,000 with a 37% margin

Company did not provide 2026 guidance due to market uncertainties

Outlook

Modulight does not provide guidance on 2026 revenue or profitability due to market uncertainty

Company transitioning to treatment session-based payment model to commercialize products

Macroeconomic and geopolitical uncertainty impacts market development, making forecasting difficult

Result Drivers

CUSTOMER ACTIVITY - Increased customer activity and successful marketing events contributed to revenue growth

EBITDA IMPROVEMENT - EBITDA margin improved due to diversification of customer portfolio and increased synergy between accounts

PPT BUSINESS MODEL - Strong growth in PPT revenue, exceeding one million euros in 2025, indicating profitable shift

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
EUR 1.74 mln
Q4 EPS
-EUR 0.02
Q4 Net Income
-EUR 651,000
Q4 EBIT
-EUR 787,000
Q4 EBITDA
EUR 641,000
Q4 Free Cash Flow From Operating Activities
-EUR 538,000


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", no "hold" and 2 "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

Wall Street's median 12-month price target for Modulight Oyj is €1.30, about 10.4% above its February 19 closing price of €1.18

Press Release: ID:nMFN7f82db

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)